Fig. 1From: Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancerXRCC4 expression in human cancers. A XRCC4 expression in TCGA tumors and adjacent normal tissues in different cancer types from the TCGA database analyzed by the TIMER database. (*P < 0.05, ** P < 0.01, ***P< 0.001). B XRCC4 expression in TCGA tumors and adjacent normal tissues analyzed by the Xiantao Academic; C XRCC4 expression in several cancers and paired normal tissue in the GEPIA database. (*P < 0.05, **P < 0.01, ***P < 0.001)Back to article page